CannaMore Biotechs Announces Successful Completion of Phase 2a Clinical Trial for Cannabidiol-Based Treatment for Ulcerative Colitis

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Source:
    PR Newswire. July 22, 2024